Meeting
2016 ASCO Quality Care Symposium
Prophylactic use of Granulocyte-colony stimulating factors (G-CSF) in cancer patients: Adherence to NCCN guidelines.
Authors
Rashi Khanna
Fairview Hospital-Cleveland Clinic, Cleveland, OH
Rashi Khanna, Vyshak Alva Venur, Shraddha Narechania, Paul Elson, Hamed Daw, Timothy Peter Spiro, Abdo Haddad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Science of Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality
Sub Track
Quality Improvement
Citation
J Clin Oncol 34, 2016 (suppl 7S; abstr 209)
DOI
10.1200/jco.2016.34.7_suppl.209
Abstract #
209
Poster Bd #
E5
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Interpreting the febrile neutropenia rates from randomized controlled trials for consideration of primary prophylaxis in the real world: A systematic review and meta-analysis.
First Author: Judy Truong
Poster
2014 ASCO Quality Care Symposium
Assessing the impact of a targeted electronic medical record intervention on growth factor usage in cancer patients.
First Author: Jordan Bernens
Poster
2013 ASCO Annual Meeting
Clinical guideline on the prophylactic use of g-CSF on neutropenia by chemotherapy.
First Author: Roberto Rivera-Luna
Poster
2013 ASCO Annual Meeting
How oncologists adhere to evidence-based G-CSF-guidelines to prevent febrile neutropenia: A sample survey in hospitals and practices in Germany.
First Author: Hartmut Link